A common polymorphism in the promoter region of the TNFSF4 gene is associated with lower allele-specific expression and risk of myocardial infarction

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ria, Massimiliano ^a,c   Lagercrantz, Jacob ^a   Samnegård, Ann ^b   Boquist, Susanna ^a   Hamsten, Anders ^a   Eriksson, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; OX40 LIGAND; TNFSF4 PROTEIN, HUMAN;

ALLELE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; IMMUNOASSAY; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MYOCARDIAL INFARCTION; OX40 LIGAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952779709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017652     Document Type: Article

References (36)

1. Godfrey WR, Fagnoni FF, Harara MA, Buck D, Engleman EG, (1994) Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med 180: 757-762.
2. Hansson GK, (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1876-1890.
3. Hori T, (2006) Roles of OX40 in the pathogenesis and the control of diseases. Int J Hematol 83: 17-22.
4. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, et al. (1987) Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A 84: 3763-3767.
5. Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, et al. (2005) Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 37: 365-372.
6. van Wanrooij EJ, van Puijvelde GH, de Vos P, Yagita H, van Berkel TJ, et al. (2007) Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204-210.
7. Koch W, Hoppmann P, Mueller JC, Schomig A, Kastrati A, (2008) Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population. Nat Genet 40: 1386-1387; author reply 1387-1388.
8. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP, (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33: 469-475.
9. Samnegård A, Silveira A, Lundman P, Boquist S, Odeberg J, et al. (2005) Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 258: 411-419.
10. Whatling C, Bjork H, Gredmark S, Hamsten A, Eriksson P, (2004) Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res 45: 1768-1776.
11. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, et al. (1999) A common functional polymorphism (C-&A substitution at position-863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8: 1443-1449.
12. Barbaro M, Balsamo A, Anderlid BM, Myhre AG, Gennari M, et al. (2009) Characterization of deletions at 9p affecting the candidate regions for sex reversal and deletion 9p syndrome by MLPA. Eur J Hum Genet 17: 1439-1447.
13. Zhu C, Odeberg J, Hamsten A, Eriksson P, (2006) Allele-specific MMP-3 transcription under in vivo conditions. Biochem Biophys Res Commun 348: 1150-1156.
14. Holmberg K, Persson ML, Uhlen M, Odeberg J, (2005) Pyrosequencing analysis of thrombosis-associated risk markers. Clin Chem 51: 1549-1552.
15. Ronaghi M, Uhlen M, Nyren P, (1998) A sequencing method based on real-time pyrophosphate. Science 281: 363, 365.
16. Alksnis M, Barkhem T, Stromstedt PE, Ahola H, Kutoh E, et al. (1991) High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J Biol Chem 266: 10078-10085.
17. Kalb VF Jr, Bernlohr RW, (1977) A new spectrophotometric assay for protein in cell extracts. Anal Biochem 82: 362-371.
18. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, et al. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268: 10739-10745.
19. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A, (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92: 1851-1855.
20. Andersen MC, Engstrom PG, Lithwick S, Arenillas D, Eriksson P, et al. (2008) In silico detection of sequence variations modifying transcriptional regulation. PLoS Comput Biol 4: e5.
21. (2004) The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306: 636-640.
22. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
23. Hikami K, Tsuchiya N, Tokunaga K, (2000) New variations in human OX40 ligand (CD134L) gene. Genes Immun 1: 521-522.
24. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W, (1995) Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2: 507-521.
25. Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J, (1996) The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 13: 447-453.
26. Wu H, Chen Y, Liang J, Shi B, Wu G, et al. (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438: 981-987.
27. Malarstig A, Eriksson P, Rose L, Diehl KA, Hamsten A, et al. (2008) Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem 54: 833-840.
28. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42: 295-302.
29. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234-1237.
30. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, et al. (1994) Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb 14: 1480-1497.
31. Weinberg AD, (2002) OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines. Trends Immunol 23: 102-109.
32. Kashiwakura J, Yokoi H, Saito H, Okayama Y, (2004) T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173: 5247-5257.
33. Stopfer P, Mannel DN, Hehlgans T, (2004) Lymphotoxin-beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells. J Immunol 172: 7459-7465.
34. Nishimoto H, Lee SW, Hong H, Potter KG, Maeda-Yamamoto M, et al. (2005) Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood 106: 4241-4248.
35. Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, et al. (1996) The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183: 2185-2195.
36. Hansson GK, Libby P, Schonbeck U, Yan ZQ, (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291.